Klaudyne Hong

Klaudyne Hong is a seasoned professional in the fields of biotechnology and artificial intelligence, currently serving as Cofounder, CEO, and CSO of Peach IntelliHealth since 2014, where novel AI/ML algorithms are developed to predict serious medical events and enhance patient outcomes. Previously, as Managing Director and Partner at Temasek Bioscience Partners LLC from 2012 to 2016, Klaudyne focused on optimizing business development and M&A strategies for biotech and medtech firms. From 2005 to 2012, Klaudyne was Team Leader at Johnson & Johnson, managing a large team to advance a cell therapy concept to First-in-Human trials. Earlier career experience includes serving as Project Representative at ScheringAG, where Klaudyne oversaw M&A due diligence and clinical asset development. Educational credentials include a PhD from the Massachusetts Institute of Technology, an MA and BA from California State University, Fresno, and a Wharton Executive Education in Organizational Leadership.